Pitfalls in [18f]fdg PeT imaging in gynecological malignancies

Miguel Hernandez Pampaloni, Luca Facchetti, Lorenzo Nardo

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Gynecologic malignancies are the leading causes of cancer in women and they represent about 10 to 20% of all solid tumors. During the past few decades, technological advancements in the detection and staging have gained a pivotal role in all oncological processes, including the gynecological ones. Beyond ultrasound, computed tomography (CT) and magnetic resonance (MR) imaging that are conventionally used for anatomical imaging, [18f]fdg imaging and its hybrid further development as PeT/cT has become a crucial tool due of its ability to combine functional metabolic and anatomic information, and the ability to image the entire whole body in a single examination. Since the introduction of integrated hybrid PET/CT systems into clinical practice the accurate analysis of the images has detected a number of limitations and pitfalls. The purpose of this review was to describe in detail the different pitfalls related to the use of [18f]fdg PeT/cT in the gynecological malignancies, providing imaging examples and discussing possible ways to avoid misinterpretations.

Original languageEnglish (US)
Pages (from-to)124-138
Number of pages15
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume60
Issue number2
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Neoplasms
Multimodal Imaging
Tomography
Magnetic Resonance Imaging

Keywords

  • Fluorodeoxyglucose F18
  • Pelvic neoplasms
  • Positron-emission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Pitfalls in [18f]fdg PeT imaging in gynecological malignancies. / Pampaloni, Miguel Hernandez; Facchetti, Luca; Nardo, Lorenzo.

In: Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 60, No. 2, 01.01.2016, p. 124-138.

Research output: Contribution to journalReview article

Pampaloni, Miguel Hernandez ; Facchetti, Luca ; Nardo, Lorenzo. / Pitfalls in [18f]fdg PeT imaging in gynecological malignancies. In: Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2016 ; Vol. 60, No. 2. pp. 124-138.
@article{5d0743167f6d4b21ae4b2c2cd2a91f71,
title = "Pitfalls in [18f]fdg PeT imaging in gynecological malignancies",
abstract = "Gynecologic malignancies are the leading causes of cancer in women and they represent about 10 to 20{\%} of all solid tumors. During the past few decades, technological advancements in the detection and staging have gained a pivotal role in all oncological processes, including the gynecological ones. Beyond ultrasound, computed tomography (CT) and magnetic resonance (MR) imaging that are conventionally used for anatomical imaging, [18f]fdg imaging and its hybrid further development as PeT/cT has become a crucial tool due of its ability to combine functional metabolic and anatomic information, and the ability to image the entire whole body in a single examination. Since the introduction of integrated hybrid PET/CT systems into clinical practice the accurate analysis of the images has detected a number of limitations and pitfalls. The purpose of this review was to describe in detail the different pitfalls related to the use of [18f]fdg PeT/cT in the gynecological malignancies, providing imaging examples and discussing possible ways to avoid misinterpretations.",
keywords = "Fluorodeoxyglucose F18, Pelvic neoplasms, Positron-emission tomography",
author = "Pampaloni, {Miguel Hernandez} and Luca Facchetti and Lorenzo Nardo",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
volume = "60",
pages = "124--138",
journal = "Quarterly Journal of Nuclear Medicine and Molecular Imaging",
issn = "1824-4785",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Pitfalls in [18f]fdg PeT imaging in gynecological malignancies

AU - Pampaloni, Miguel Hernandez

AU - Facchetti, Luca

AU - Nardo, Lorenzo

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Gynecologic malignancies are the leading causes of cancer in women and they represent about 10 to 20% of all solid tumors. During the past few decades, technological advancements in the detection and staging have gained a pivotal role in all oncological processes, including the gynecological ones. Beyond ultrasound, computed tomography (CT) and magnetic resonance (MR) imaging that are conventionally used for anatomical imaging, [18f]fdg imaging and its hybrid further development as PeT/cT has become a crucial tool due of its ability to combine functional metabolic and anatomic information, and the ability to image the entire whole body in a single examination. Since the introduction of integrated hybrid PET/CT systems into clinical practice the accurate analysis of the images has detected a number of limitations and pitfalls. The purpose of this review was to describe in detail the different pitfalls related to the use of [18f]fdg PeT/cT in the gynecological malignancies, providing imaging examples and discussing possible ways to avoid misinterpretations.

AB - Gynecologic malignancies are the leading causes of cancer in women and they represent about 10 to 20% of all solid tumors. During the past few decades, technological advancements in the detection and staging have gained a pivotal role in all oncological processes, including the gynecological ones. Beyond ultrasound, computed tomography (CT) and magnetic resonance (MR) imaging that are conventionally used for anatomical imaging, [18f]fdg imaging and its hybrid further development as PeT/cT has become a crucial tool due of its ability to combine functional metabolic and anatomic information, and the ability to image the entire whole body in a single examination. Since the introduction of integrated hybrid PET/CT systems into clinical practice the accurate analysis of the images has detected a number of limitations and pitfalls. The purpose of this review was to describe in detail the different pitfalls related to the use of [18f]fdg PeT/cT in the gynecological malignancies, providing imaging examples and discussing possible ways to avoid misinterpretations.

KW - Fluorodeoxyglucose F18

KW - Pelvic neoplasms

KW - Positron-emission tomography

UR - http://www.scopus.com/inward/record.url?scp=84992665652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992665652&partnerID=8YFLogxK

M3 - Review article

C2 - 26937887

AN - SCOPUS:84992665652

VL - 60

SP - 124

EP - 138

JO - Quarterly Journal of Nuclear Medicine and Molecular Imaging

JF - Quarterly Journal of Nuclear Medicine and Molecular Imaging

SN - 1824-4785

IS - 2

ER -